Sagent Pharms Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SAGENT PHARMS INC, and what generic and branded alternatives to SAGENT PHARMS INC drugs are available?
SAGENT PHARMS INC has fifty-six approved drugs.
Summary for Sagent Pharms Inc
| US Patents: | 0 |
| Tradenames: | 48 |
| Ingredients: | 47 |
| NDAs: | 56 |
Drugs and US Patents for Sagent Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sagent Pharms Inc | CLINDAMYCIN PHOSPHATE | clindamycin phosphate | INJECTABLE;INJECTION | 090109-001 | Sep 30, 2011 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Sagent Pharms Inc | PHENYLEPHRINE HYDROCHLORIDE | phenylephrine hydrochloride | SOLUTION;INTRAVENOUS | 209967-002 | Jan 16, 2020 | AP1 | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Sagent Pharms Inc | VECURONIUM BROMIDE | vecuronium bromide | INJECTABLE;INJECTION | 078274-001 | Dec 29, 2008 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Sagent Pharms Inc | PROPOFOL | propofol | INJECTABLE;INJECTION | 075102-001 | Jan 4, 1999 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
